Startups
2009
NANOTHERAPIX S.L.Advanced therapy drugs (ATMP) based on the use of the patient's own autologous blood cells genetically modified ex vivo by means of a specific adenoviral-type vector.
Company ceased activity in 2019
Company ceased activity in 2019
Address
Barcelona, Spain
CERCA ownership
Badalona, Spain
1995
IGTP
Other Catalan Public owners
Logo
Logo
Status & Deeptech areas
Company Status & Company Deeptech AreasCurrent company status
DeepTech Area
Spinoff information
Company Description
NanoTherapix is a technology-based company interested in the design and development of technologies, services, knowledge, molecules and products for application in the field of biotechnology and biomedicine. It was born from the collaboration of researchers from the Autonomous University of Barcelona and the Germans Trias i Pujol Health Sciences Research Institute Foundation.
Product description
We developed modified monocytes that selectively access to inflamed areas releasing the therapeutic protein.
Company Closed or Exit Year